Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7381 to 7395 of 8314 results

  1. Obesity in children and young people: prevention and lifestyle weight management programmes (QS94)

    This quality standard has been updated and replaced by NICE quality standard 212.

  2. Obesity in adults: prevention and lifestyle weight management programmes (QS111)

    This quality standard has been updated and replaced by NICE quality standard 212.

  3. Diabetes in adults (QS6)

    This quality standard is updated and replaced by the quality standards on type 1 diabetes in adults (QS208) and type 2 diabetes in adults (QS209).

  4. Dementia: support in health and social care (QS1)

    This quality standard has been updated and replaced by NICE quality standard 184

  5. Obesity: clinical assessment and management (QS127)

    This quality standard has been updated and replaced by NICE quality standard 212.

  6. Smoking: supporting people to stop (QS43)

    This quality standard has been updated and replaced by NICE quality standard 207.

  7. Glaucoma in adults (QS7)

    This quality standard has been updated and replaced by NICE quality standard 180.

  8. Epilepsy in adults (QS26)

    This quality standard has been updated and replaced by NICE quality standard 211

  9. Epilepsy in children and young people (QS27)

    This quality standard has been updated and replaced by NICE quality standard 211

  10. Venous thromboembolism in adults: diagnosis and management (QS29)

    This quality standard has been updated and replaced by NICE quality standard QS201.

  11. Venous thromboembolism in adults: reducing the risk in hospital (QS3)

    This quality standard has been updated and replaced by NICE quality standard QS201.

  12. Dementia: independence and wellbeing (QS30)

    This quality standard has been updated and replaced by NICE quality standard 184

  13. Moderately to severely active ulcerative colitis: adalimumab (ESNM6)

    This evidence summary has been replaced by NICE technology appraisal guidance 329.

  14. Type 2 diabetes: dulaglutide (ESNM59)

    This evidence summary has been updated and replaced by NICE guideline NG28.